Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIFUROXAZIDE: 71 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
71
Total FAERS Reports
20 (28.2%)
Deaths Reported
54
Hospitalizations
71
As Primary/Secondary Suspect
17
Life-Threatening

First Report: 19980313 · Latest Report: 20230530

What Are the Most Common NIFUROXAZIDE Side Effects?

#1 Most Reported
Toxicity to various agents
18 reports (25.4%)
#2 Most Reported
Coma
18 reports (25.4%)
#3 Most Reported
Cardiomyopathy
12 reports (16.9%)

All NIFUROXAZIDE Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Coma 18 25.4% 12 11
Toxicity to various agents 18 25.4% 11 17
Cardiomyopathy 12 16.9% 12 10
Confusional state 11 15.5% 11 10
Coronary artery stenosis 11 15.5% 11 10
Drug interaction 11 15.5% 9 11
Encephalopathy 11 15.5% 11 10
Hepatic enzyme increased 11 15.5% 11 10
Hyperglycaemia 11 15.5% 11 10
Jaundice 11 15.5% 11 10
Myocarditis 11 15.5% 11 10
Respiratory depression 11 15.5% 11 10
Somnolence 11 15.5% 11 10
White blood cell count increased 11 15.5% 11 10
Accidental poisoning 10 14.1% 10 10
Cardiac disorder 10 14.1% 10 10
Cardio-respiratory arrest 10 14.1% 10 10
Cholecystitis infective 10 14.1% 10 10
Drug screen false positive 10 14.1% 10 10
Hepatic cytolysis 10 14.1% 10 10

Who Reports NIFUROXAZIDE Side Effects? Age & Gender Data

Gender: 57.4% female, 42.6% male. Average age: 48.5 years. Most reports from: FR. View detailed demographics →

Is NIFUROXAZIDE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2012 1 0 0
2014 1 0 1
2016 15 12 13
2017 9 0 8
2018 4 0 4
2019 1 0 1
2020 12 0 10
2023 6 0 0

View full timeline →

What Is NIFUROXAZIDE Used For?

IndicationReports
Product used for unknown indication 41
Diarrhoea 11

Official FDA Label for NIFUROXAZIDE

Official prescribing information from the FDA-approved drug label.